May Cannabis M&A: Vireo Closes Four Deals, Cannabist Exits

May 2026 cannabis M&A deals are being written almost entirely by one company. Vireo Growth closed four transactions and announced a fifth in roughly six weeks, building a total footprint of more than 160 dispensaries across 10 states while absorbing Hawthorne Gardening’s approximately $110 million balance sheet contribution. On the other end of the spectrum, Cannabist, once a marquee multi-state company (MSO), filed Chapter 15 bankruptcy and signed deals to sell its Ohio and Delaware permits for a combined $63.5 million, on top of a separate $130 million Virginia exit that closed in February. Between Vireo’s aggressive roll-up and Cannabist’s forced exits, the two storylines define where the industry stands right now: disciplined consolidators are buying, and the over-leveraged are selling.

🔥 MARKET SIGNALS THIS MONTH:

• Vireo Growth executes five transactions in about six weeks – One company now operates in 10 states with 160+ dispensaries after closing Schwazze, Eaze, Hawthorne, and the ACE Venture New York restructuring, then announcing FLUENT on April 30
• First major MSO to access U.S. bankruptcy court protection via Chapter 15 – Cannabist filed Chapter 15 on March 25, believed to be the first major cannabis MSO to use bankruptcy rather than receivership. The mechanism is novel: only the Canadian holding companies are debtors, while the U.S. plant-touching subsidiaries are non-debtors protected derivatively through Chapter 15’s recognition of the Canadian CCAA proceeding. The filing followed definitive deals signed March 23 to sell Ohio assets to Holistic Industries ($47M) and Delaware assets to Parma Holdco ($16.5M). A separate $130M Virginia sale to Parma had already closed February 5. Six additional state operations are under non-binding MOU for sale.
• Out-of-state wholesale platform signs deal for New Jersey entry – Nabis announced May 4 a strategic partnership to acquire Hudson Distribution’s NJ cannabis distribution license, with the New Jersey wholesale platform expected to launch in the second half of 2026; the deal would mark Nabis’s entry into its fourth US state market once finalized
• Legacy horticultural capital enters Vireo platform – Scotts Miracle-Gro’s Good Dog Holdings received 213 million Vireo shares plus warrants for Hawthorne Gardening assets, representing a legacy horticultural company converting a major cannabis ancillary position into equity in a licensed cannabis company

🔥 New York – Majority Stake Acquisition

ACE Venture of NY, LLC, a MWBE-certified holding company led by Steven Acevedo, announced May 5 the completion of its 51% acquisition of Vireo Health of New York, creating what is expected to become New York’s first scaled social equity operator emerging from the state’s first minority-owned vertically integrated medical cannabis license. Vireo NY has operated cultivation, manufacturing, and retail infrastructure since 2014, with Vireo retaining 49% and continuing to provide operational and compliance support.

Announced Complete May 5, 2026; Underlying Operating Agreement Executed March 31, 2026

🔥 New Jersey – License Acquisition

Nabis, the largest licensed cannabis wholesale platform with over $1 billion in annual commerce across California, Nevada, and New York, announced May 4 a strategic partnership with Hudson Distribution Services LLC to acquire its New Jersey cannabis distribution license and warehouse lease. Hudson Distribution and affiliated parties will become shareholders in Nabis’s New Jersey operations through a seed investment, and Nabis expects to launch its New Jersey wholesale platform in the second half of 2026.

Announced May 4, 2026; Financial terms not disclosed

Delaware / Ohio / Virginia – Distressed Asset Sales

On March 23, Cannabist signed definitive agreements to sell its Ohio cannabis operations to Holistic Industries for $47 million ($34.5M cash + $12.5M promissory note) and its Delaware assets to Parma Holdco for $16.5 million cash — combined $63.5 million. Two days later, on March 25, Cannabist and its Canadian parent commenced CCAA proceedings in Ontario and Chapter 15 proceedings in U.S. Bankruptcy Court. A separate Virginia sale to Parma Holdco for $130 million had already closed February 5, 2026, with proceeds used to redeem $84.5 million of 9.25% senior secured notes and $6.5 million of 9.0% senior secured convertible notes.

Delaware deal expected Q2 2026; Ohio deal expected Q3 2026; both subject to regulatory approval

🔥 Florida – Acquisition

Vireo Growth announced April 30 a definitive agreement to acquire FLUENT Corp. in an all-stock transaction, with each FLUENT shareholder receiving 0.0705359 Vireo subordinate voting shares per FLUENT share. FLUENT generated $71.5 million in Florida revenue in 2025 and operates 37 active retail locations and 8 cultivation and manufacturing facilities across Florida, New York, and Texas. The combined Vireo-FLUENT Florida platform is expected to reach approximately 74 stores and approximately 144,000 square feet of cultivation and production canopy upon closing. Vireo will also convert $30 million of FLUENT’s existing debt into equity.

Announced April 30, 2026; Closing expected Q4 2026, subject to FLUENT shareholder approval

🔥 Colorado / New Mexico – Acquisition

Vireo Growth completed its acquisition of 45 dispensaries (24 in Colorado, 21 in New Mexico) and two manufacturing facilities from distressed MSO Schwazze (Medicine Man Technologies) via a credit bid of approximately $111 million of Schwazze’s 13% senior secured notes. The transaction was valued at under 4x pro forma EBITDA. Financing is layered: Vireo’s newly formed NewCo entered into a senior secured term loan facility with Chicago Atlantic affiliates for approximately $62.7 million across two tranches, plus a separate $26 million term loan facility at 20% fixed interest.

Closed March 19, 2026

Colorado – Definitive Agreement

Verdant Capital Partners signed a definitive agreement to acquire 17 of Native Roots’ 21 retail dispensaries in Colorado. Native Roots will retain four retail locations and its cultivation and manufacturing facilities. The deal reflects a pattern of mid-tier buyers targeting profitable single-state retail portfolios rather than full-company acquisitions.

Signed March 3, 2026; Pending regulatory approval; Financial terms not disclosed

🔥 California / Colorado – Acquisition

Vireo Growth closed its acquisition of Eaze Inc. on April 1, adding 67 active retail locations across California, Florida, and Colorado and over 12 million completed deliveries to Vireo’s platform. Vireo issued 90,379,591 subordinate voting shares as closing consideration at a base value of approximately $47 million and a potential earnout tied to $76.8 million imputed EBITDA. The deal gives Vireo immediate entry into California and Florida and adds 15 dispensaries to Vireo’s Colorado footprint.

Closed April 1, 2026

California – Brand Acquisition

LEEF Brands closed its acquisition of Standard Holdings Inc., the parent company of HIMALAYA VAPOR, a leading California-based cannabis concentrates brand known for premium full-spectrum cartridges and natural formulations made from sun-grown cannabis. Total consideration was approximately US$2.5 million, comprising 13,688,000 LEEF common shares and warrants with an aggregate value of US$100,000 priced at $0.25 CAD per share. LEEF plans to supply HIMALAYA with low-cost inputs from its Salisbury Canyon Ranch cultivation platform.

Announced April 16, 2026; Closed April 28, 2026

🔥 National – Asset Acquisition

Vireo Growth completed its acquisition of The Hawthorne Gardening Company LLC from The Scotts Miracle-Gro Company on April 8, issuing 213 million subordinate voting shares and 80 million warrants (at $0.85 per share for five years) to Good Dog Holdings LLC in exchange for $35 million in cash, approximately $58 million in net working capital, and $20 million in inventory (primarily growing media, to be supplied over two years). The transaction contributes approximately $110 million in combined cash and net working capital to Vireo’s balance sheet, with Scotts subsidiary Good Dog Holdings receiving approximately 14% equity in Vireo.

Closed April 8, 2026

Vireo’s Six-Week Roll-Up

In roughly 45 days, Vireo Growth went from a regional multi-state company to a major cannabis retail platform. The Schwazze close (March 19) added 45 distressed dispensaries in two Mountain West states at under 4x EBITDA – a price that reflects the forced nature of Schwazze’s exit rather than a market premium. The Eaze close (April 1) added 67 locations across three states and – critically – Eaze’s delivery technology and California footprint, two assets Vireo could not have built organically. The Hawthorne acquisition (April 8) converted an existing relationship with Scotts Miracle-Gro into an approximately $110 million balance sheet injection, reducing Vireo’s capital risk while giving Scotts an equity stake in the combined platform. The FLUENT announcement on April 30 layers on top of all of this, potentially deepening Vireo’s Florida footprint to approximately 74 combined stores if regulators approve. What Vireo is building is not just a retail footprint – it’s a platform that includes supply chain capabilities (through Hawthorne), delivery (Eaze), social equity positioning (ACE Venture in New York), and retail scale in mature and emerging markets. The risk is execution.

Vireo’s acquisition pace stands out in this market cycle. Five closed or announced transactions representing hundreds of millions in disclosed and implied value signals either extraordinary management conviction or a race to consolidate before rescheduling fully prices in.

Cannabist’s bankruptcy is a warning to leveraged SSOs and MSOs. Filing Chapter 15 with $270 million owed to lenders and the IRS – and selling off state permits at whatever the market will bear – is the forced-exit scenario that every owner in this newsletter should be stress-testing against their own balance sheet right now.

Distressed-to-disciplined deal flow is the defining theme of May 2026 cannabis M&A. Schwazze sold at a credit bid. Cannabist sold under bankruptcy. Native Roots signed an agreement to sell 17 stores. Each buyer paid under market for stabilized cash flow, which is the only deal structure getting done at scale.

Schedule III’s 280E relief is narrow but real for medical operators. The April 23 DOJ final order moves only two categories of marijuana to Schedule III: FDA-approved drug products and marijuana subject to a state-issued medical marijuana license. Recreational and adult-use cannabis remains in Schedule I, and 280E continues to apply to those operations. For a state-licensed medical operator, the change can drop effective tax rates from 70-90% to approximately 21%; for a mixed-use operator selling both medical and adult-use, the IRS has signaled forthcoming guidance on apportioning 280E by activity.

New Jersey is becoming a distribution battleground. Nabis entering NJ with the Hudson Distribution license signals that the $1 billion-plus NJ adult-use market has become large enough to support a professional wholesale infrastructure layer – the same dynamic that played out in California and New York before large distributors consolidated those markets.

Current Acquisition Opportunities

CannDev has curated a portfolio of cannabis licenses and operational assets available for immediate acquisition. These opportunities span multiple states and represent turnkey entry points for strategic buyers.

Option 1: Turnkey Package

Asking: $4,000,000

• Fully awarded Florida MMTC license with turnkey facility lease in place
• Includes cultivation, processing, and dispensing equipment plus key operational assets
• Positioned for rapid state approvals and immediate operational scale

Option 2: Paper Only

Asking: $2,500,000

• Clean, fully awarded Florida MMTC license in a highly constrained market
• No facility or operational assets included
• Ideal for buyers seeking flexibility on buildout and execution strategy

Washington DC Medical Retail License

Asking: $25,000

• DC medical cannabis retailer license eligible to be placed at any compliant property
• Seller will assist buyer with sourcing a compliant location
• Low cost entry opportunity into the expanding Washington DC regulated cannabis market

General Provisional Licenses

Asking: Approximately $400,000

• Pricing on general provisional licenses has softened, creating an attractive entry point
• Multiple licenses currently available for operators entering the New York market
• Strong opportunity to establish market position ahead of continued rollout and expansion

Brooklyn Retail Dispensary

Asking: $2,000,000

• Performing location averaging approximately $200K/month in sales within first 7 months
• Approximately 2,800 sq ft footprint with lounge component and long term lease in place
• Over $1M invested in buildout, approximately 13% EBITDA (pre management fee)
• Delivery operations recently launched
• Seller financing available with 50% down

📬 Track Cannabis M&A Every Month

Get monthly cannabis M&A deal flow, valuation data, and market signals delivered to your inbox. Built for investors and executives evaluating acquisition timing.